Estimating the penetrance of genetic variants linked to cardiomyopathy

21 May 2022 (16:21 - 16:30)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Mr Remco De Brouwer

University Medical Centre Groningen, Groningen (Netherlands (The))

5 More presentations in this session

Presentation thumbnail

Clinical characterization and natural history of chemotherapy-induced dilated cardiomyopathy

Doctor A. Lalario (Trieste, IT)

Abstract Slides Video

Presentation thumbnail

Prognostic implication of neutrophil-lymphocyte ratio (NLR) in myocarditis: results from a multicentre, multinational study.

Doctor A. Cannata (London, GB)

Abstract Slides Video

Presentation thumbnail

Exercise oxygen kinetic in hypertrophic cardiomyopathy: results from a multicenter cardiopulmonary exercise testing study

Doctor M. Mapelli (Milan, IT)

Abstract Slides Video

Presentation thumbnail

Echocardiographic findings in subjects with an amyloidogenic apolipoprotein A1 mutation

Doctor A. Aimo (Pisa, IT)

Abstract Slides Video

Presentation thumbnail

Redefining the epidemiology of cardiac amyloidosis. A systematic review of screening studies

Doctor A. Aimo (Pisa, IT)

Abstract Slides Video

Access the full session

Session thumbnail

Highlight on cardiomyopathy

The Event

Event poster

Heart Failure 2022

21 May 2022 16:21 CET

You may be interested in

Congress Presentation

Disease penetrance in genotype-positive relatives from families with dilated cardiomyopathy

Congress Presentation

Beyond monogenic Hypertrophic cardiomyopathy: multiple variant presence drives severe early-onset phenotypes in children

Congress Presentation

Exploring the association between genetic markers and ICD discharge rate in hypertrophic cardiomyopathy

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources